12 Feb Multidrug Resistant Bacteria Found Commonly In Oncology Intensive Care
MedicalResearch: What is the background for this study?
Dr. Cornejo: Critically ill patients in the intensive care unit are at major risk of hospital-acquired infections. Immunosuppressed patients have a higher risk related with continuous exposure to the hospital setting, mucositis and disruption of skin integrity, presence of indwelling catheters and abnormal immune system because of primary malignancy or chemotherapy. Our aimed was to investigate prevalence and outcome of hospital-acquired infections in an oncology ICU.
MedicalResearch: What are the main findings?
Dr. Cornejo: We found that hospital-acquired infections are a major problem in the ICU. Hospital-acquired infections are related with higher mortality. Multidrug resistant bacteria are frequently involved in these infections, and are associated with increased mortality.
MedicalResearch: What should clinicians and patients take away from this report?
Dr. Cornejo: Prevalence of hospital-acquired infections at this oncologic ICU is high as well as Multidrug resistant bacteria isolates; both factors are associated with a higher mortality. Antimicrobial stewardship, including focused and rigorous interventions by multidisciplinary team should help to limit the problem and improve the outcomes.
MedicalResearch: What recommendations do you have for future research as a result of this study?
Dr. Cornejo: This study was retrospective, so in the future we will carry out a prospective research, it could let to control some confounding variables, and expand the sample. Additionally we implemented and reinforced some strategies; the impact will be measured in a near future.
MedicalResearch.com Interview with:, & Dr. Cornejo-Juárez (2015). Multidrug Resistant Bacteria Found Commonly In Oncology Intensive Care MedicalResearch.com